Physician profile
Bruce S Tenner
NPI 1841244332
$2,673.57
in general payments reported to CMS, 2019-2025
29 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $311 · 2021: $281 · 2022: $168 · 2023: $262 · 2024: $694 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,412.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $497.41 | 2020-2025 | |
| Boston Scientific Corporation | $330.52 | 2019-2025 | Patientcare Link, Watchman Flx, Bodyguardian |
| Janssen Pharmaceuticals, INC | $294.09 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $207.52 | 2019-2020 | |
| Novo Nordisk INC | $158.81 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Ironshore Pharmaceuticals INC. | $158.59 | 2019 | |
| Medtronic, INC. | $136.13 | 2021 | |
| Philips North America LLC | $112.27 | 2022-2025 | (5044) Mcot, Mcot, Event |
| Abbott Laboratories | $79.69 | 2020-2022 | |
| Pfizer INC. | $78.40 | 2019-2024 | |
| Lilly USA, LLC | $69.51 | 2024-2025 | Zepbound, Mounjaro |
| Heartflow, INC. | $67.69 | 2024-2025 | |
| Cvrx, INC. | $55.65 | 2024 | Barostim Neo System |
| Amgen INC. | $47.03 | 2024-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.68 | 2021-2025 | Jardiance |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.73 | 2023-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $31.19 | 2023-2024 | Verquvo |
| Baxter Healthcare | $31.06 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $28.55 | 2022-2023 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $27.61 | 2024 | Farxiga |
| Impulse Dynamics (USA) INC. | $27.53 | 2024 | Optimizer |
| Edwards Lifesciences Corporation | $27.39 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Irhythm Technologies, INC. | $21.00 | 2023 | Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $19.97 | 2024 | |
| Daiichi Sankyo INC. | $19.58 | 2022 | |
| Kestra Medical Technology Services, INC. | $16.22 | 2024 | Assure Wcd |
| Dexcom, INC. | $15.92 | 2025 | Dexcom G6 Transmitter |
| Kiniksa Pharmaceuticals, LTD. | $15.29 | 2023 | Arcalyst |
| Astellas Pharma US INC | $14.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Tenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.